Merck Surges 5.67% and Approaches 52-Week High as Bulls Take Control

By TrendSpider Editor

Merck & Company, Inc. is posting a sharp 5.67% gain on Friday, May 22, 2026, with shares climbing to $122.44 and pushing toward the upper boundary of the stock's 52-week range of $75.40 to $125.14. Today's rally marks a significant breakout from yesterday's session, where MRK traded in a narrow band

Merck Surges 5.67% and Approaches 52-Week High as Bulls Take Control

Merck & Company, Inc. is posting a sharp 5.67% gain on Friday, May 22, 2026, with shares climbing to $122.44 and pushing toward the upper boundary of the stock's 52-week range of $75.40 to $125.14. Today's rally marks a significant breakout from yesterday's session, where MRK traded in a narrow band between $112.14 and $115.98, meaning the stock has blown well past its prior day's high. With the current price sitting just $2.70 below the 52-week peak, bulls are now watching closely to see whether MRK can push through to fresh annual highs.

Key Drivers of the MRK Stock Move

The forward setup for MRK is technically compelling but not without risk. A confirmed close above $125.14 would establish a new 52-week high and potentially open the door to further upside discovery with limited technical overhead. However, today's gap above the prior session range means there is a notable air pocket of support below current prices, and any reversal could pull shares back toward the $112 to $116 zone relatively quickly. Investors will want to watch whether volume and buying pressure are sustained through the close on this Friday session, or whether the move fades as the trading week wraps up.

MRK Seasonality

Late May has historically been a transitional period for pharmaceutical stocks, with portfolio repositioning ahead of summer often creating volatility around names that have seen large single-session moves. A strong close on the final trading day of the week in late May could set a constructive tone heading into the summer months for MRK.

MRK Relative Performance

With a 5.67% single-session gain, MRK is outperforming on a relative basis compared to a typical trading day in the pharmaceutical sector. The stock's current price of $122.44 sits dramatically above its 52-week low of $75.40, reflecting a recovery of more than 62% from that trough level, and today's move brings the stock to within approximately 2.2% of its annual peak at $125.14.